These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1835904)

  • 1. S-100 immunoreactive interdigitating cells in normal and in Down's syndrome human thymuses.
    Aita M; Franzé A; Gabrielli F
    Cell Biol Int Rep; 1991 Aug; 15(8):645-59. PubMed ID: 1835904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of anti-keratins and anti-thymostimulin antibodies in normal and in Down's syndrome human thymuses.
    Aita M; Amantea A
    Thymus; 1991 May; 17(3):155-65. PubMed ID: 1712130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and immunohistochemical study of Down syndrome thymus.
    Larocca LM; Lauriola L; Ranelletti FO; Piantelli M; Maggiano N; Ricci R; Capelli A
    Am J Med Genet Suppl; 1990; 7():225-30. PubMed ID: 2149952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic deficiency in Down's syndrome.
    Levin S; Schlesinger M; Handzel Z; Hahn T; Altman Y; Czernobilsky B; Boss J
    Pediatrics; 1979 Jan; 63(1):80-7. PubMed ID: 155804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical distribution of S-100 protein in patients with Down's syndrome.
    Michetti F; Larocca LM; Rinelli A; Lauriola L
    Acta Neuropathol; 1990; 80(5):475-8. PubMed ID: 2147533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in thymocyte subpopulations in Down's syndrome (trisomy 21).
    Larocca LM; Piantelli M; Valitutti S; Castellino F; Maggiano N; Musiani P
    Clin Immunol Immunopathol; 1988 Nov; 49(2):175-86. PubMed ID: 2971489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic extracellular matrix in Down's syndrome.
    Fonseca EC; Lannes-Vieira J; Villa-Verde DM; Savino W
    Braz J Med Biol Res; 1989; 22(8):971-4. PubMed ID: 2534476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesis.
    Griffin WS; Sheng JG; McKenzie JE; Royston MC; Gentleman SM; Brumback RA; Cork LC; Del Bigio MR; Roberts GW; Mrak RE
    Neurobiol Aging; 1998; 19(5):401-5. PubMed ID: 9880042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down's syndrome: problems of immunodeficiency.
    Ugazio AG
    Hum Genet Suppl; 1981; 2():33-9. PubMed ID: 6218139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive oxygen intermediates during programmed cell death induced in the thymus of the Ts(1716)65Dn mouse, a murine model for human Down's syndrome.
    Paz-Miguel JE; Flores R; Sánchez-Velasco P; Ocejo-Vinyals G; Escribano de Diego J; López de Rego J; Leyva-Cobián F
    J Immunol; 1999 Nov; 163(10):5399-410. PubMed ID: 10553065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymic epithelial abnormalities in patients with congenital heart disease and Down's syndrome.
    Dybdahl H; Henriques UV
    APMIS; 1993 Jan; 101(1):73-4. PubMed ID: 8457328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of CD8/CD4 ratio in the fetal thymic parenchyme in Down's syndrome.
    Tamiolakis D; Venizelos I; Kotini A; Nikolaidou S; Papadopoulos N
    Acta Medica (Hradec Kralove); 2003; 46(4):179-82. PubMed ID: 14965170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical comparative investigations of lymphatic tissue in reactive processes, myasthenic thymuses and Hodgkin's disease.
    Zółtowska A
    Arch Immunol Ther Exp (Warsz); 1995; 43(1):15-22. PubMed ID: 8744679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thymus morphology in Down's syndrome].
    Medvedev NIu; Popova ED
    Arkh Patol; 1982; 44(6):27-30. PubMed ID: 6215018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and ultrastructure of S-100-immunoreactive cells in the human thymus.
    Ushiki T; Iwanaga T; Masuda T; Takahashi Y; Fujita T
    Cell Tissue Res; 1984; 235(3):509-14. PubMed ID: 6713483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components.
    Eimoto T; Kusano T; Ando K; Kikuchi M; Shirakusa T; Kawanami S
    Am J Clin Pathol; 1990 Jul; 94(1):36-43. PubMed ID: 2193507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological and immunohistological study of the developing and involuting superficial cervical thymus in the koala (Phascolarctos cinereus).
    Canfield P; Hemsley S; Connolly J
    J Anat; 1996 Aug; 189 ( Pt 1)(Pt 1):159-69. PubMed ID: 8771407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, immunological and histopathological evidence for thymic deficiency in Down's syndrome (mongolism).
    Schlesinger M; Levin S; Handzel Z; Hahn T; Altman Y; Chernobilski B; Bos J
    Adv Exp Med Biol; 1976; 66():665-71. PubMed ID: 131476
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemoglobin concentration, hematocrit and leukocyte distribution pattern in children with Down's syndrome].
    Bartelik S
    Pediatr Pol; 1995 Jun; 70(6):467-71. PubMed ID: 8692603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte surface markers and serum immunoglobulins in persons with Down's syndrome.
    Hann HW; Deacon JC; London WT
    Am J Ment Defic; 1979 Nov; 84(3):245-51. PubMed ID: 160754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.